Key Highlights
- Shares are trading down 8.34% intraday to $34.35, from a prior close of $37.47
- Second quarter 2026 Revenue was $973 million, up 49% year over year, beating the $972.3 million estimate
- Adjusted EPS of $0.90 beat the $0.80 estimate by 12.5%
- Decline comes despite investors digesting a revenue guide for next quarter that came in slightly below top-line estimates
- Pullback follows a strong post-earnings rally earlier in the week, with the stock extending that rally last week
- Full-year 2026 adjusted EPS guidance was raised to $3.3 to $4.1, while revenue guidance was reaffirmed
- Market Capitalization stands at $1.70 billion, with a 52-week range of $18.08 to $51.60
Shares Decline as Investors Reassess Growth Durability
Astrana Health (NASDAQ:ASTH) shares are trading down 8.34% intraday to $34.35, from a prior close of $37.47. The decline comes despite the company reporting a second quarter Earnings beat and receiving a price-target hike to $55 from Truist, as investors reassess durability of the company's growth amid Margin concerns following the report.
Revenue of $973 million grew 49% year over year, beating the $972.3 million estimate, and adjusted EPS of $0.90 beat the $0.80 estimate by 12.5%. The pullback appears driven by a revenue guide for next quarter that came in slightly below top-line estimates, suggesting investors are focused on forward growth expectations rather than the quarter that was just reported.
What Astrana Health Does
Astrana Health, formerly known as Apollo Medical Holdings, is a leading physician-centric, technology-powered, risk-bearing healthcare management company headquartered in Alhambra, California, rebranded under its current name in February 2024. The company operates through three segments: Care Partners, Care Delivery, and Care Enablement, leveraging an integrated end-to-end technology platform that made support for more than 12,000 Americans across Medicare, Medicaid, commercial, and ACA Marketplace plans.
Astrana acts as the broader entity connecting the healthcare ecosystem through its Management Services Organization, Independent Physician Associations, and Accountable Care Organizations, offering comprehensive care coordination to patients, families, physicians, specialists, hospitals, and health plans. In 2025, the company reported approximately $3.18 billion in revenue, reflecting 58% year-over-year growth, underscoring its rapid expansion as one of the largest value-based care platforms in the country.
Balance Sheet Strength Amid Margin Scrutiny
The pullback follows a strong post-earnings rally that had extended last week's Q2 results and analyst upgrades, with the stock's post-earnings gains reaching nearly 5% before investors began digesting Q2 results and reassessment of durability as weigh against thinner net margins of 1.05% and broader Volatility across Health Insurance and managed care peers, several of which have also sold off after Q2 reports despite beating estimates.
The company's Balance Sheet and Cash Flow improved meaningfully, with free cash flow in the first half of 2026 reaching 89% EBITDA conversion, and net Leverage down to 3.8 times from 4.2 times, with net leverage projected to reach 2.5 times by the end of the transaction, achieved in half the planned time. Medical cost trend is tracking slightly better than the company's assumption of approximately 5.2%, with Medicare Advantage and original Medicare favorable in line, and Commercial slightly above expectations.
Conclusion
Astrana Health's intraday decline despite a clear second quarter earnings beat illustrates how forward-looking guidance and margin durability concerns can outweigh a strong quarterly print in investor sentiment, particularly amid broader volatility across the managed care sector. With the company's balance sheet strengthening and medical cost trends tracking favorably against its own assumptions, the pullback appears tied more to near-term growth reassessment than to a fundamental change in the company's underlying value-based care Business model.






Please wait processing your request...